NEW MATERIAL: A compd. represented by formula I (one of R1 and R2 is OH, alkoxy or acyloxy and the other is H, and when R2 is H, an α-stereoisomer is obtained and, when R1 is H, a β-stereoisomer is obtained; R3 is H or COR4; R4 is R6 or perfluoroalkyl; R6 is substd. or non-substd. alkyl or aryl).
EXAMPLE: 3-N-trifluoroacetylaminomethyl-2,3,4,6-tetradeoxy-L-lyxohexopyranose.
USE: An intermediate of novel anthracycline having cytotoxity and stability high in treatment effect at a cancer drug.
PROCESS: A compd. represented by formula 10 obtained by reducing a compd. represented by formula 8a is treated with a compd. represented by formula CF3COOR5 (R5 is alkyl) and, subsequently, an acetal group is hydrolyzed if desired and, further, an alcohol group is esterified if desired to obtain compds. Ia-Ic. These compds. can be derived to novel substances represented by formula 2 by the acid catalyst reaction with anthracyclinones.
JIYANNPIEERU JIESON
JIYANNKUROODO JIYAKUSHI
HANSU PEETAA KUREEMAA
BEHRINGWERKE AG
Next Patent: GLYCOSIDASE INHIBITOR SALBOSTATIN AND PRODUCTION THEREOF